Potential limitations of plasmapheresis in treatment of COVID-19 patients : How to overcome them?

Errataetall:

CommentOn: Ther Apher Dial. 2021 Apr;25(2):248-249. - PMID 32510799

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy - Vol. 25, No. 3 (2021), p. 350

Language:

English

Contributors:

Daoud, Ahmed M
Soliman, Karim M
Ali, Hatem K

Links:

Volltext

Keywords:

*COVID-19
Comment
Humans
Letter
Plasmapheresis
SARS-CoV-2

Notes:

Date Completed 06.05.2021

Date Revised 06.05.2021

published: Print-Electronic

CommentOn: Ther Apher Dial. 2021 Apr;25(2):248-249. - PMID 32510799

Citation Status MEDLINE

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1111/1744-9987.13568

PMID:

32710694

PPN (Catalogue-ID):

NLM31378972X